Daré Bioscience (DARE) Institutional Ownership → The new financial threat that could wipe out millions… (From InvestorPlace) (Ad) Free DARE Stock Alerts $0.31 0.00 (0.00%) (As of 05/8/2024 ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Daré Bioscience (NASDAQ:DARE)CurrentInstitutional OwnershipPercentage6.70%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$2.99MNumber ofInstitutional Sellers(last 12 months)0 Get DARE Insider Trade Alerts Want to know when executives and insiders are buying or selling Daré Bioscience stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data DARE Institutional Buying and Selling by Quarter Ad InvestorPlace$21,000 in profits in six weeks? On Wednesday, May 8, the legendary Jonathan Rose is holding his first ever Masters in Trading Summit. Jonathan is one of the sharpest traders I’ve ever met. He made millions trading in the pits of the world’s largest exchanges.Click here for details. Daré Bioscience Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/15/2023Armistice Capital LLC6,470,000$2.99M0.0%N/A7.370% 5/1/2023Virtu Financial LLC32,481$34K0.0%-58.1%0.038% 2/8/2023 Founders Financial Securities LLC114,000$95K0.0%-67.2%0.134% 11/7/2022Virtu Financial LLC68,242$68K0.0%+29.2%0.080% 10/27/2022 Founders Financial Securities LLC347,824$5.27M0.9%+236.1%0.410% 7/27/2022 Founders Financial Securities LLC103,500$127K0.0%N/A0.122% Get the Latest News and Ratings for DARE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Daré Bioscience and its competitors with MarketBeat's FREE daily newsletter. 7/19/2022Commonwealth Equity Services LLC43,579$53K0.0%+57.8%0.051% 5/11/2022 GSA Capital Partners LLP125,954$188K0.0%-11.2%0.150% 5/10/2022Buckingham Strategic Partners30,000$45K0.0%+200.0%0.036% 2/14/2022 GSA Capital Partners LLP141,843$284K0.0%+1,077.5%0.185% 2/8/2022 Raymond James Financial Services Advisors Inc.30,000$60K0.0%N/A0.039% 11/15/2021 HighTower Advisors LLC22,035$36K0.0%-26.6%0.031% 11/12/2021Renaissance Technologies LLC324,030$541K0.0%+346.4%0.459% 11/10/2021Goldman Sachs Group Inc.255,282$426K0.0%+1,349.9%0.362% 11/9/2021BlackRock Inc.122,725$205K0.0%-9.0%0.174% 10/19/2021Interwest Venture Management Co.62,065$104K0.0%+23.2%0.088% 10/15/2021 Paradigm Strategies in Wealth Management LLC23,105$39K0.0%+131.1%0.033% 8/16/2021State Street Corp62,630$118K0.0%N/A0.127% 8/13/2021Renaissance Technologies LLC72,590$137K0.0%-91.7%0.147% 8/13/2021Geode Capital Management LLC310,318$586K0.0%+19.7%0.629% 8/13/2021Vanguard Group Inc.1,941,258$3.67M0.0%+37.2%3.934% 8/12/2021XTX Topco Ltd14,101$27K0.0%N/A0.029% 8/11/2021Commonwealth Equity Services LLC25,875$48K0.0%+55.6%0.052% 8/6/2021 HighTower Advisors LLC30,035$57K0.0%+87.3%0.061% 5/19/2021Virtu Financial LLC149,593$253K0.0%+549.5%0.303% 5/19/2021Squarepoint Ops LLC142,133$240K0.0%N/A0.288% 5/17/2021Goldman Sachs Group Inc.24,555$41K0.0%-78.8%0.052% 5/13/2021Renaissance Technologies LLC872,408$1.47M0.0%+23.3%1.844% 5/12/2021Geode Capital Management LLC259,243$438K0.0%+22.8%0.548% 5/12/2021CIBC Private Wealth Group LLC25,000$42K0.0%N/A0.053% 5/10/2021 HighTower Advisors LLC16,035$27K0.0%-49.9%0.034% 5/4/2021Commonwealth Equity Services LLC16,625$28K0.0%N/A0.035% 2/10/2021 HighTower Advisors LLC32,034$42K0.0%+33.3%0.077% 2/4/2021 GSA Capital Partners LLP144,323$193K0.0%N/A0.347% 8/12/2020 Founders Financial Securities LLC97,500$102K0.0%+387.5%0.362% 8/10/2020 HighTower Advisors LLC26,034$26K0.0%+62.4%0.097% 8/7/2020Virtu Financial LLC41,320$41K0.0%N/A0.153% 5/1/2020UBS Group AG38,502$32K0.0%N/A0.154% (Data available from 1/1/2016 forward) DARE Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of DARE shares? During the previous two years, the following institutional investors and hedge funds held shares of Daré Bioscience shares: Armistice Capital LLC ($2.99M), GSA Capital Partners LLP ($188K), Founders Financial Securities LLC ($95K), Commonwealth Equity Services LLC ($53K), and Buckingham Strategic Partners ($45K), Virtu Financial LLC ($34K).Learn more on DARE's institutional investors. What percentage of Daré Bioscience stock is owned by institutional investors? 6.70% of Daré Bioscience stock is owned by institutional investors. Learn more on DARE's institutional investor holdings. Which institutional investors have been buying Daré Bioscience stock? The following institutional investors have purchased Daré Bioscience stock in the last 24 months: Armistice Capital LLC ($6.47M), Founders Financial Securities LLC ($347.82K), Buckingham Strategic Partners ($20K), Commonwealth Equity Services LLC ($15.95K), and Virtu Financial LLC ($15.42K). How much institutional buying is happening at Daré Bioscience? Institutional investors have bought a total of 6,869,201 shares in the last 24 months. This purchase volume represents approximately $3.42M in transactions. Which Daré Bioscience major shareholders have been selling company stock? The following institutional investors have sold Daré Bioscience stock in the last 24 months: Founders Financial Securities LLC ($233.82K), Virtu Financial LLC ($44.99K), and GSA Capital Partners LLP ($15.89K). How much institutional selling is happening at Daré Bioscience? Institutional investors have sold a total of 294,701 shares in the last 24 months. This volume of shares sold represents approximately $264.54K in transactions. Related Companies: CASI Pharmaceuticals Major Shareholders Theratechnologies Major Shareholders DURECT Major Shareholders Fortress Biotech Major Shareholders Viracta Therapeutics Major Shareholders Spruce Biosciences Major Shareholders ImmunoPrecise Antibodies Major Shareholders NextCure Major Shareholders Aprea Therapeutics Major Shareholders BriaCell Therapeutics Major Shareholders This page (NASDAQ:DARE) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaAI “wealth window” is closing June 25thParadigm PressThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldHe Is Giving Away BitcoinCrypto Swap ProfitsGold Set to EXPLODE!Gold Safe ExchangeCharles Payne Demystifies OptionsUnstoppable ProsperityShocking: One AI startup's revenue could surge 4,735%Manward Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Daré Bioscience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.